• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥厚型心肌病猫的血小板活化

Platelet activation in cats with hypertrophic cardiomyopathy.

作者信息

Tablin F, Schumacher T, Pombo M, Marion C T, Huang K, Norris J W, Jandrey K E, Kittleson M D

机构信息

Department of Anatomy, Physiology and Cell Biology, School of Veterinary Medicine, University of California Davis, Davis, CA.

出版信息

J Vet Intern Med. 2014 Mar-Apr;28(2):411-8. doi: 10.1111/jvim.12325. Epub 2014 Feb 24.

DOI:10.1111/jvim.12325
PMID:24612013
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4857988/
Abstract

BACKGROUND

Cats with hypertrophic cardiomyopathy (HCM) are at risk for development of systemic thromboembolic disease. However, the relationship between platelet activation state and cardiovascular parameters associated with HCM is not well described.

OBJECTIVES

To characterize platelet activation by flow cytometric evaluation of platelet P-selectin and semiquantitative Western blot analysis of soluble platelet-endothelial cell adhesion molecule-1 (sPECAM-1).

ANIMALS

Eight normal healthy cats (controls) owned by staff and students of the School of Veterinary Medicine and 36 cats from the UC Davis Feline HCM Research Laboratory were studied.

METHODS

Platelet-rich plasma (PRP) was used for all flow cytometry studies. Platelet surface CD41 and P-selectin expression were evaluated before and after ADP stimulation. sPECAM-1 expression was evaluated by Western blot analysis of platelet-poor plasma that had been stabilized with aprotinin. Standard echocardiographic studies were performed.

RESULTS

Resting platelets from cats with severe HCM had increased P-selectin expression compared to controls, and expressed higher surface density of P-selectin reflected by their increased mean fluorescence intensities (MFI). Stimulation with ADP also resulted in significantly increased P-selectin MFI of platelets from cats with severe HCM. Increased P-selectin expression and MFI correlated with the presence of a heart murmur and end-systolic cavity obliteration (ESCO). sPECAM-1 expression from cats with moderate and severe HCM was significantly increased above those of control cats.

CONCLUSIONS AND CLINICAL IMPORTANCE

P-selectin and sPECAM expression may be useful biomarkers indicating increased platelet activation in cats with HCM.

摘要

背景

患有肥厚型心肌病(HCM)的猫有发生全身性血栓栓塞性疾病的风险。然而,血小板活化状态与HCM相关心血管参数之间的关系尚未得到充分描述。

目的

通过流式细胞术评估血小板P-选择素以及可溶性血小板-内皮细胞黏附分子-1(sPECAM-1)的半定量蛋白质印迹分析来表征血小板活化情况。

动物

研究了兽医学院教职工和学生拥有的8只正常健康猫(对照组)以及来自加州大学戴维斯分校猫科HCM研究实验室的36只猫。

方法

所有流式细胞术研究均使用富血小板血浆(PRP)。在ADP刺激前后评估血小板表面CD41和P-选择素的表达。通过对用抑肽酶稳定的乏血小板血浆进行蛋白质印迹分析来评估sPECAM-1的表达。进行标准超声心动图研究。

结果

与对照组相比,患有严重HCM的猫的静息血小板P-选择素表达增加,其平均荧光强度(MFI)增加反映出P-选择素的表面密度更高。用ADP刺激也导致患有严重HCM的猫的血小板P-选择素MFI显著增加。P-选择素表达和MFI的增加与心脏杂音和收缩末期腔室闭塞(ESCO)的存在相关。中度和重度HCM猫的sPECAM-1表达明显高于对照猫。

结论及临床意义

P-选择素和sPECAM表达可能是表明HCM猫血小板活化增加的有用生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/971d706becc8/JVIM-28-411-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/e7b7f218944d/JVIM-28-411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/816a3ddad3a0/JVIM-28-411-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/c8c8459cc84e/JVIM-28-411-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/fdee92b9d892/JVIM-28-411-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/447c19d2359f/JVIM-28-411-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/971d706becc8/JVIM-28-411-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/e7b7f218944d/JVIM-28-411-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/816a3ddad3a0/JVIM-28-411-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/c8c8459cc84e/JVIM-28-411-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/fdee92b9d892/JVIM-28-411-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/447c19d2359f/JVIM-28-411-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2f1/4857988/971d706becc8/JVIM-28-411-g006.jpg

相似文献

1
Platelet activation in cats with hypertrophic cardiomyopathy.肥厚型心肌病猫的血小板活化
J Vet Intern Med. 2014 Mar-Apr;28(2):411-8. doi: 10.1111/jvim.12325. Epub 2014 Feb 24.
2
Platelet function in clinically healthy cats and cats with hypertrophic cardiomyopathy: analysis using the Platelet Function Analyzer-100.临床健康猫和肥厚型心肌病猫的血小板功能:使用血小板功能分析仪-100进行分析
Vet Clin Pathol. 2008 Dec;37(4):385-8. doi: 10.1111/j.1939-165X.2008.00062.x.
3
Doppler echocardiographic evaluation of midventricular obstruction in cats with hypertrophic cardiomyopathy.肥厚型心肌病猫的心室中部梗阻的多普勒超声心动图评估
J Vet Intern Med. 2013 Nov-Dec;27(6):1416-20. doi: 10.1111/jvim.12175. Epub 2013 Sep 3.
4
Analytical validation of platelet microparticle quantification in cats.猫血小板微粒定量的分析验证
Vet Clin Pathol. 2018 Sep;47(3):386-395. doi: 10.1111/vcp.12641.
5
Systolic and diastolic myocardial dysfunction in cats with hypertrophic cardiomyopathy or systemic hypertension.肥厚型心肌病或系统性高血压猫的收缩期和舒张期心肌功能障碍。
J Vet Intern Med. 2006 Sep-Oct;20(5):1106-15. doi: 10.1892/0891-6640(2006)20[1106:sadmdi]2.0.co;2.
6
Plasma cardiac troponin I concentration and cardiac death in cats with hypertrophic cardiomyopathy.肥厚型心肌病猫的血浆心肌肌钙蛋白I浓度与心源性死亡
J Vet Intern Med. 2014 Nov-Dec;28(6):1731-7. doi: 10.1111/jvim.12459. Epub 2014 Oct 15.
7
Azotemia in cats with feline hypertrophic cardiomyopathy: prevalence and relationships with echocardiographic variables.猫肥厚型心肌病伴发氮质血症:患病率及其与超声心动图变量的关系
J Vet Cardiol. 2008 Dec;10(2):117-23. doi: 10.1016/j.jvc.2008.09.002. Epub 2008 Nov 21.
8
Layer-specific myocardial function in asymptomatic cats with obstructive hypertrophic cardiomyopathy assessed using 2-dimensional speckle-tracking echocardiography.使用二维斑点追踪超声心动图评估无症状梗阻性肥厚型心肌病猫的心肌各层特异性功能。
J Vet Intern Med. 2019 Jan;33(1):37-45. doi: 10.1111/jvim.15339. Epub 2018 Nov 29.
9
Evaluation of coagulation markers in the plasma of healthy cats and cats with asymptomatic hypertrophic cardiomyopathy.健康猫和无症状肥厚型心肌病猫血浆中凝血标志物的评估。
Vet Clin Pathol. 2007 Jun;36(2):167-72. doi: 10.1111/j.1939-165x.2007.tb00203.x.
10
Prognostic indicators in cats with hypertrophic cardiomyopathy.肥厚型心肌病猫的预后指标。
J Vet Intern Med. 2013 Nov-Dec;27(6):1427-36. doi: 10.1111/jvim.12215. Epub 2013 Oct 17.

引用本文的文献

1
Evolving FATE: A New Lens on the Pathogenesis and Management of Feline Cardiogenic Arterial Thromboembolism.不断演变的命运:猫心源性动脉血栓栓塞症发病机制与治疗的新视角
Animals (Basel). 2025 Jun 1;15(11):1630. doi: 10.3390/ani15111630.
2
Evaluation of selected inflammatory markers in cats with feline infectious peritonitis before and after therapy.猫传染性腹膜炎猫治疗前后所选炎症标志物的评估。
BMC Vet Res. 2025 May 9;21(1):330. doi: 10.1186/s12917-025-04731-x.
3
A novel technique to characterize procoagulant platelet formation and evaluate platelet procoagulant tendency in cats by flow cytometry.

本文引用的文献

1
Increased mean platelet volume in hypertrophic cardiomyopathy.肥厚型心肌病患者的平均血小板体积增加。
Angiology. 2014 May;65(5):420-4. doi: 10.1177/0003319713483919. Epub 2013 Apr 5.
2
Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy.家猫肌球蛋白结合蛋白 C DNA 变异体(A31P、A74T、R820W)及其与肥厚型心肌病的关系。
J Vet Intern Med. 2013 Mar-Apr;27(2):275-85. doi: 10.1111/jvim.12031. Epub 2013 Jan 17.
3
Lyn and PECAM-1 function as interdependent inhibitors of platelet aggregation.
一种通过流式细胞术表征促凝血血小板形成并评估猫血小板促凝血倾向的新技术。
Front Vet Sci. 2024 Dec 16;11:1480756. doi: 10.3389/fvets.2024.1480756. eCollection 2024.
4
Evaluation of clopidogrel response in healthy cats using a novel viscoelastic test and thromboelastography.使用新型粘弹性测试和血栓弹力图评估健康猫对氯吡格雷的反应。
Front Vet Sci. 2024 Jun 18;11:1371781. doi: 10.3389/fvets.2024.1371781. eCollection 2024.
5
Synergistic inhibitory effects of clopidogrel and rivaroxaban on platelet function and platelet-dependent thrombin generation in cats.氯吡格雷和利伐沙班对猫血小板功能和血小板依赖性凝血酶生成的协同抑制作用。
J Vet Intern Med. 2023 Jul-Aug;37(4):1390-1400. doi: 10.1111/jvim.16727. Epub 2023 May 19.
6
Platelet Priming and Activation in Naturally Occurring Thermal Burn Injuries and Wildfire Smoke Exposure Is Associated With Intracardiac Thrombosis and Spontaneous Echocardiographic Contrast in Feline Survivors.自然发生的热烧伤和野火烟雾暴露中血小板的预激和激活与猫科动物幸存者的心内血栓形成和自发超声心动图造影有关。
Front Vet Sci. 2022 Jul 14;9:892377. doi: 10.3389/fvets.2022.892377. eCollection 2022.
7
Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Cats With Hypertrophic Cardiomyopathy.中性粒细胞与淋巴细胞比值在肥厚型心肌病猫中的预后价值
Front Vet Sci. 2022 Mar 14;9:813524. doi: 10.3389/fvets.2022.813524. eCollection 2022.
8
Evaluation of hemostasis in hyperthyroid cats.评估甲状腺功能亢进症猫的止血功能。
J Vet Intern Med. 2021 Nov;35(6):2636-2645. doi: 10.1111/jvim.16274. Epub 2021 Sep 30.
9
A genetic polymorphism in P2RY impacts response to clopidogrel in cats with hypertrophic cardiomyopathy.P2RY 基因多态性影响肥厚型心肌病猫对氯吡格雷的反应。
Sci Rep. 2021 Jun 15;11(1):12522. doi: 10.1038/s41598-021-91372-3.
10
Updates on Laboratory Evaluation of Feline Cardiac Diseases.猫心脏疾病实验室评估的最新进展。
Vet Sci. 2021 Mar 3;8(3):41. doi: 10.3390/vetsci8030041.
林和 PECAM-1 作为血小板聚集的相互依赖的抑制剂发挥作用。
Blood. 2011 Apr 7;117(14):3903-6. doi: 10.1182/blood-2010-09-304816. Epub 2011 Feb 4.
4
Feline hypertrophic cardiomyopathy: an update.猫肥厚型心肌病:最新进展
Vet Clin North Am Small Anim Pract. 2010 Jul;40(4):685-700. doi: 10.1016/j.cvsm.2010.04.004.
5
PECAM-1: conflicts of interest in inflammation.PECAM-1:炎症中的利益冲突。
Life Sci. 2010 Jul 17;87(3-4):69-82. doi: 10.1016/j.lfs.2010.06.001. Epub 2010 Jun 10.
6
Analysis of 8 sarcomeric candidate genes for feline hypertrophic cardiomyopathy mutations in cats with hypertrophic cardiomyopathy.对患有肥厚性心肌病的猫的8个肌节候选基因进行猫肥厚性心肌病突变分析。
J Vet Intern Med. 2009 Jul-Aug;23(4):840-3. doi: 10.1111/j.1939-1676.2009.0341.x.
7
A shear gradient-dependent platelet aggregation mechanism drives thrombus formation.一种依赖剪切梯度的血小板聚集机制驱动血栓形成。
Nat Med. 2009 Jun;15(6):665-73. doi: 10.1038/nm.1955.
8
Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.血浆N末端脑钠肽前体(NT-proBNP)浓度用于筛查猫肥厚性心肌病的研究。
J Vet Cardiol. 2009 May;11 Suppl 1:S63-70. doi: 10.1016/j.jvc.2009.02.005. Epub 2009 Apr 22.
9
Biomarkers of pathophysiology in hypertrophic cardiomyopathy: implications for clinical management and prognosis.肥厚型心肌病病理生理学的生物标志物:对临床管理和预后的影响。
Eur Heart J. 2009 Jan;30(2):139-51. doi: 10.1093/eurheartj/ehn538. Epub 2009 Jan 9.
10
Standardization of platelet-derived microparticle counting using calibrated beads and a Cytomics FC500 routine flow cytometer: a first step towards multicenter studies?使用校准微珠和Cytomics FC500常规流式细胞仪对血小板衍生微粒计数进行标准化:迈向多中心研究的第一步?
J Thromb Haemost. 2009 Jan;7(1):190-7. doi: 10.1111/j.1538-7836.2008.03200.x. Epub 2008 Oct 18.